EIM
HSTO

Essex Investment Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Essex Investment Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-452
Closed -$531K – 435
2018
Q1 		$531K Buy
+452
New +$500K 0.07% 264

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.55% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Essex Investment Management's HSTO Position: Q2 2018 in Review

Essex Investment Management sold out of Histogen Inc. Common Stock (HSTO) in Q2 2018, closing a stake of 452 shares — an estimated $531K sold.

Essex Investment Management first reported a position in HSTO in Q1 2018 and held it in 1 quarter. The position peaked at $531K in Q1 2018. 61 funds tracked by Wall St. Rank hold HSTO as of Q2 2018.

  • Essex Investment Management reported no remaining Histogen Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Essex Investment Management sold 452 Histogen Inc. Common Stock shares in Q2 2018, an estimated $531K.
  • Essex Investment Management first reported a position in Histogen Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Essex Investment Management's Histogen Inc. Common Stock position peaked at $531K in Q1 2018.
  • 61 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2018.

Based on Essex Investment Management's 13F filing for Q2 2018, filed 17 Jul 2018.